GSK plc Buys Back Own Shares
Ticker: GLAXF · Form: 6-K · Filed: May 8, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | May 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-buyback, stock-transaction
TL;DR
GSK is buying back its own stock via Citigroup.
AI Summary
GSK plc announced on May 8, 2025, that it purchased a number of its own ordinary shares through its corporate stockbroker, Citigroup Global Markets Limited. The filing details transactions in its own shares for the month of May 2025.
Why It Matters
Share buybacks can signal management's confidence in the company's valuation and potentially increase earnings per share.
Risk Assessment
Risk Level: low — This is a routine filing regarding share transactions and does not introduce new material risks.
Key Players & Entities
- GSK plc (company) — Registrant
- Citigroup Global Markets Limited (company) — Corporate stockbroker
- May 2025 (date) — Reporting period for share transactions
- May 8, 2025 (date) — Date of announcement
FAQ
What specific number of GSK plc ordinary shares were purchased?
The filing states that a 'number' of ordinary shares were purchased, but the exact quantity is not specified in the provided text.
Who acted as GSK's corporate stockbroker for these transactions?
Citigroup Global Markets Limited acted as GSK's corporate stockbroker.
What is the reporting period for these share transactions?
The report is for the month of May 2025.
What is the par value of GSK plc's ordinary shares?
The ordinary shares have a par value of 31¼ pence each.
Is GSK plc required to file annual reports under Form 20-F or Form 40-F?
GSK plc indicates it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 8, 2025 regarding GSK plc (GLAXF).